Thursday 21 September 2017

Global Companion Diagnostics Market 2017 to 2025 - Share, Growth, Trends and Forecast By Acute Market Reports

Companion Diagnostics Market – (Technology Type – Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization Test, Gene Sequencing and Others; Indication Type – Oncology, Cardiovascular Diseases, Infectious Diseases and Autoimmune Diseases): Growth, Future Prospects and Competitive Analysis, 2017-2025, the market was valued at USD 50,92.5 Mn in 2015, and is expected to reach USD 41,191.9 Mn by 2025, expanding at a CAGR of 18.5% from 2017 to 2025.


Market Insights
Companion diagnostic tests are used to identify suitable patients for administering specific drugs and monitoring the prognosis of drug effects on the disease. This concept of combining a drug with a diagnostic test is known as predictive medicine or personalized medicine. A companion diagnostic test has the ability to predict the risks of the disease and monitor its therapeutic response. On the basis of technology the companion diagnostics market has been segmented into polymerase chain reaction, immunohistochemistry, In-situ hybridization test, gene sequencing and others. The others segment includes tests such as monoclonal antibodies test and cellular immune testing.
The polymerase chain reaction technique is the largest segment in the global companion diagnostics market. On the basis of indication the global companion diagnostics market has been segmented as oncology, cardiovascular diseases, virology and autoimmune diseases.
The oncology segment has been further segmented on the basis of various cancers such as breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma and other cancer.


The oncology segment held the largest market in the global companion diagnostics by indication and is expected to be the highest grossing segment through the forecast period. The major factors driving the oncology segment include development of majority of companion diagnostics for detection of various cancer biomarkers.
The geographical segmentation of the global companion diagnostics market comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In base year 2015, North America accounted for the largest market in the global companion diagnostics. In North America, the US represented the largest market for companion diagnostic tests. Asia Pacific is expected to grow at a highest rate during the forecast period due increased adoption, technological advancements, and demand for personalized medicine. the increase in the prevalence of cancer and associated disorders, the increase in healthcare expenditure, and the increase in the level of awareness among the population.
Thus, the APAC region is expected to adopt companion diagnostics tests at a rapid rate during the forecast period.
The key players operating in the global companion diagnostics market include Abbott Laboratories Inc., Agilent Technologies Inc., bioMerieux SA, Qiagen N.V., Roche Holdings AG, Thermo Fisher Scientific Inc. The other notable players include Ventana Medical Systems, Myriad Genetics, Leica Microsystems and others.

Browse All Reports of This Category: http://www.acutemarketreports.com/category/market-research

Table of Content :
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Global Companion Diagnostics Market Portaiture
2.2 Global Companion Diagnostics Market, by Indication, 2015 (USD Mn)
2.3 Global Companion Diagnostics Market, by Technology, 2015 (USD Mn)
2.4 Companion Diagnostics Market Share, by Geography, 2015 (Value %)
Chapter 3 Companion Diagnostics : Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Epidemiology of Thyroid Disorders
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increased Focus on Cost Cutting in Drug Discovery and Development
3.3.1.2 Increased Popularity of Personalized Medicines
3.3.1.3 Rapid Advancements in Science and Technology
3.3.1.4 Increase in Prevalence of Cancer and Other Disorders
3.3.2 Challenges
3.3.2.1 High Cost Involved in Companion Diagnostics Development
3.3.1.2 Stringent Regulations
3.3.1.3 Need for Multidisciplinary Approach to Develop Efficient Companion Diagnostics
3.3.3 Opportunities
3.3.3.1 Increase in Number of Product Launches and Approvals
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis By Key Players, 2015 (Value %)
3.6 Vendor Landscape
Chapter 4 Companion Diagnostics Market, by Indications
4.1 Preface
4.2 Oncology
4.2.1. Breast Cancer
4.2.2. Colorectal Cancer
4.2.1. Gastric Cancer
4.2.2. Lung Cancer
4.2.1. Melanoma
4.2.2. Others
4.3 Cardiovascular Diseases
4.4 Infectious Diseases
4.5 Autoimmune Diseases

About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:
Name : Chris Paul
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)